The metabolic syndrome represents a plethora of cardio-metabolic risk factors including obesity, arterial hypertension, atherogenic dyslipidemia, hyperglycemia, accompanied by pro-inflammatory and pro-thrombotic state. The metabolic syndrome is one of the key risk factors for certain types of cancer. Among these malignancies, breast cancer and endometrial neoplasms require special attention. Incriminated major causes for the development of breast and endometrial cancer in metabolic syndrome patients are: the pro-inflammatory status and related cytokines, adipokine imbalances, hyperestrogenism, growth factors, disturbances in cancer microenvironment, insulin resistance and hyperinsulinemia. The metabolic syndrome consists of molecular dysregulations that create a pro-oncogenic status. Our review aims at providing a better understanding of the mechanisms underlying the link between the metabolic syndrome and endometrial and breast cancer.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Lazar, Andrada-Luciana; Vulturar, Romana; Fodor, Adriana; Orasan, Olga Hilda; Crișan, Camil-Horia Eusebiu; Login, Cezar; Para, Ioana; Negrean, Vasile; Tiperciuc, Brandusa; and Cozma, Angela
"The molecular mechanisms linking metabolic syndrome to endometrial and breast cancers,"
Journal of Mind and Medical Sciences: Vol. 8:
2, Article 2.
Available at: https://scholar.valpo.edu/jmms/vol8/iss2/2